Martha Demski
Director/Board Member at CHIMERIX, INC.
Net worth: 334 542 $ as of 2024-03-30
Profile
Martha J.
Demski is currently an Independent Director at Alpha Teknova, Inc., Lead Independent Director at Chimerix, Inc., and Independent Director at Equillium, Inc. She previously served as an Independent Director at ADMA Biologics, Inc., Adamas Pharmaceuticals LLC, Neothetics, Inc., and Bank of America Corp.
She was also the Chief Financial Officer & Senior Vice President at Ajinomoto Althea, Inc., Chief Operating & Financial Officer at Sidney Kimmel Cancer Center, and Senior Vice President at US Trust.
Ms. Demski's early career includes being the Chief Financial Officer & Vice President at Vical, Inc. She holds an undergraduate degree from Michigan State University and an MBA from The University of Chicago Booth School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ADMA BIOLOGICS, INC.
0.01% | 2023-03-31 | 30,786 ( 0.01% ) | 203 188 $ | 2024-03-30 |
CHIMERIX, INC.
0.08% | 2023-06-08 | 72,055 ( 0.08% ) | 76 378 $ | 2024-03-30 |
EQUILLIUM, INC.
0.07% | 2023-05-21 | 23,799 ( 0.07% ) | 54 976 $ | 2024-03-30 |
Martha Demski active positions
| Companies | Position | Start |
|---|---|---|
| CHIMERIX, INC. | Director/Board Member | 2023-07-31 |
| EQUILLIUM, INC. | Director/Board Member | 2018-08-31 |
| ALPHA TEKNOVA, INC. | Director/Board Member | 2023-08-30 |
Former positions of Martha Demski
| Companies | Position | End |
|---|---|---|
| ADMA BIOLOGICS, INC. | Director/Board Member | 2023-06-05 |
| ADAMAS PHARMACEUTICALS, INC. | Director/Board Member | 2021-11-23 |
Neothetics, Inc.
 Neothetics, Inc. Pharmaceuticals: MajorHealth Technology Neothetics, Inc. operates as a holding company, which provides clinical-stage specialty pharmaceutical and developing therapeutics for the aesthetic. It focuses on localized fat reduction and body contouring. The company products include LIPO-202, is an injectable formulation of the long-acting ß2-adrenergic receptor agonist, salmeterol xinafoate. Neothetics was founded by John D. Dobak in February 2007 and is headquartered in San Diego, CA. | Director/Board Member | 2017-12-31 |
Ajinomoto Althea, Inc.
 Ajinomoto Althea, Inc. Medical SpecialtiesHealth Technology Ajinomoto Althea, Inc. provides biopharmaceutical contract development and manufacturing services to biotechnology and pharmaceutical companies worldwide. It offers development services in the areas of process development, protein formulation technology, analytical development and validation, and regulatory support. The company was founded by Magda Marquet and Francois Ferre in 1998 and is headquartered in San Diego, CA. | Director of Finance/CFO | 2017-04-30 |
Sidney Kimmel Cancer Center
 Sidney Kimmel Cancer Center Medical/Nursing ServicesHealth Services Part of Sanford Burnham Prebys Medical Discovery Institute, Sidney Kimmel Cancer Center provides medical research services. The private company is based in San Diego, CA. Sidney Kimmel Cancer Center was acquired by Sanford Burnham Prebys Medical Discovery Institute on June 23, 2009 for $25 million. | Director of Finance/CFO | 2010-11-30 |
Training of Martha Demski
| Michigan State University | Undergraduate Degree |
| The University of Chicago Booth School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 5 |
|---|---|
| MERRILL LYNCH PREFERRED CAPITAL TRUST I | Finance |
| CHIMERIX, INC. | Health Technology |
| ADMA BIOLOGICS, INC. | Health Technology |
| ALPHA TEKNOVA, INC. | Health Technology |
| EQUILLIUM, INC. | Health Technology |
| Private companies | 6 |
|---|---|
Vical, Inc.
 Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | Health Technology |
Adamas Pharmaceuticals LLC
 Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Adamas Pharmaceuticals, Inc. engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products include GOCOVRI, ADS-5012, ADS-4101, and Namzaric. GOCOVRI is indicated for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy. ADS-5102 is a treatment for walking impairment in patients with multiple sclerosis. ADS-401 treats partial onset seizures in patients with epilepsy. Namzaric is a drug treatment for moderate to severe Alzheimer's disease. The company was founded by Gregory T. Went on November 15, 2000 and is headquartered in Emeryville, CA. | Health Technology |
Ajinomoto Althea, Inc.
Ajinomoto Althea, Inc. Medical SpecialtiesHealth Technology Ajinomoto Althea, Inc. provides biopharmaceutical contract development and manufacturing services to biotechnology and pharmaceutical companies worldwide. It offers development services in the areas of process development, protein formulation technology, analytical development and validation, and regulatory support. The company was founded by Magda Marquet and Francois Ferre in 1998 and is headquartered in San Diego, CA. | Health Technology |
Sidney Kimmel Cancer Center
Sidney Kimmel Cancer Center Medical/Nursing ServicesHealth Services Part of Sanford Burnham Prebys Medical Discovery Institute, Sidney Kimmel Cancer Center provides medical research services. The private company is based in San Diego, CA. Sidney Kimmel Cancer Center was acquired by Sanford Burnham Prebys Medical Discovery Institute on June 23, 2009 for $25 million. | Health Services |
| US Trust | Finance |
Neothetics, Inc.
Neothetics, Inc. Pharmaceuticals: MajorHealth Technology Neothetics, Inc. operates as a holding company, which provides clinical-stage specialty pharmaceutical and developing therapeutics for the aesthetic. It focuses on localized fat reduction and body contouring. The company products include LIPO-202, is an injectable formulation of the long-acting ß2-adrenergic receptor agonist, salmeterol xinafoate. Neothetics was founded by John D. Dobak in February 2007 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Martha Demski
